Patents by Inventor Yeon Hee Cho

Yeon Hee Cho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition including stem cell-derived microvesicles for promoting neurogenesis
    Patent number: 10406180
    Abstract: The present invention relates to a composition including stem cell-derived microvesicles as an active ingredient for promoting neurogenesis. The stem cell-derived microvesicles according to the present invention can promote neurogenesis and migration of nerves and also promote angiogenesis in vascular endothelial cells, and thus can be usefully used in treatment of neurological damage.
    Type: Grant
    Filed: July 14, 2017
    Date of Patent: September 10, 2019
    Assignee: Samsung Life Public Welfare Foundation
    Inventors: Oh Young Bang, Gyeong Joon Moon, Yeon Hee Cho, Suk Jae Kim, Dong Hee Kim, Ji Hee Sung
  • Composition comprising ischemic serum for promoting activation of stem cell and method for promoting activation of stem cell
    Patent number: 10072247
    Abstract: The present invention relates to a composition comprising an ischemic serum for promoting the activation of a stem cell, to a method for promoting the activation of a stem cell and to a stem cell, the activation of which is promoted by the composition or the method. The ischemic serum according to the present invention may stimulate the stem cell to facilitate the secretion of a growth factor, improve survival rate, improve mobility to an injured part, improve proliferation rate and maintain characteristics of the stem cell, thus promoting an activation of the stem cell such that the stem cell becomes suitable for transplantation of the stem cell to a patient having a brain injury.
    Type: Grant
    Filed: October 4, 2013
    Date of Patent: September 11, 2018
    Assignee: Samsung Life Public Welfare Foundation
    Inventors: Oh Young Bang, Gyeong Joon Moon, Yeon Hee Cho, Suk Jae Kim, Dong Hee Kim, Soo Kyung Ryoo, Ji Hyun Lee, Ji Yoon Nam, Ji Hee Sung
  • BIOMARKER FOR DIAGNOSIS OF MOYAMOYA DISEASE
    Publication number: 20180030535
    Abstract: Provided are a biomarker composition for the diagnosis of moyamoya disease, including caveolin-1, a kit for the diagnosis of moyamoya disease, a method of providing information for moyamoya disease diagnosis, and a method of screening a moyamoya disease therapeutic agent. According to the present disclosure, specific treatment for moyamoya disease is possible by distinguishing the disease from atherosclerosis, which is a similar cerebrovascular stenosis disease, and thus unnecessary factors or risk factors that may be accompanied by side effects may be avoided and, therefore, may be applied to effective MMD therapies.
    Type: Application
    Filed: July 25, 2017
    Publication date: February 1, 2018
    Inventors: Oh Young BANG, Gyeong Joon MOON, Jong-Won CHUNG, Mi Jeong OH, Dong Hee KIM, Soo Yoon KIM, Yeon Hee CHO
  • COMPOSITION INCLUDING STEM CELL-DERIVED MICROVESICLES FOR PROMOTING NEUROGENESIS
    Publication number: 20170368103
    Abstract: The present invention relates to a composition including stem cell-derived microvesicles as an active ingredient for promoting neurogenesis. The stem cell-derived microvesicles according to the present invention can promote neurogenesis and migration of nerves and also promote angiogenesis in vascular endothelial cells, and thus can be usefully used in treatment of neurological damage.
    Type: Application
    Filed: July 14, 2017
    Publication date: December 28, 2017
    Inventors: Oh Young Bang, Gyeong Joon Moon, Yeon Hee Cho, Suk Jae Kim, Dong Hee Kim, Ji Hee Sung
  • Composition Comprising Ischemic Serum for Promoting Activation of Stem Cell and Method for Promoting Activation of Stem Cell
    Publication number: 20150337264
    Abstract: The present invention relates to a composition comprising an ischemic serum for promoting the activation of a stem cell, to a method for promoting the activation of a stem cell and to a stem cell, the activation of which is promoted by the composition or the method. The ischemic serum according to the present invention may stimulate the stem cell to facilitate the secretion of a growth factor, improve survival rate, improve mobility to an injured part, improve proliferation rate and maintain characteristics of the stem cell, thus promoting an activation of the stem cell such that the stem cell becomes suitable for transplantation of the stem cell to a patient having a brain injury.
    Type: Application
    Filed: October 4, 2013
    Publication date: November 26, 2015
    Inventors: Oh Young Bang, Gyeong Joon Moon, Yeon Hee Cho, Suk Jae Kim, Dong Hee Kim, Soo Kyung Ryoo, Ji Hyun Lee, Ji Yoon Nam, Ji Hee Sung
  • COMPOSITION INCLUDING STEM CELL-DERIVED MICROVESICLES FOR PROMOTING NEUROGENESIS
    Publication number: 20150045298
    Abstract: The present invention relates to a composition including stem cell-derived microvesicles as an active ingredient for promoting neurogenesis. The stem cell-derived microvesicles according to the present invention can promote neurogenesis and migration of nerves and also promote angiogenesis in vascular endothelial cells, and thus can be usefully used in treatment of neurological damage.
    Type: Application
    Filed: August 14, 2012
    Publication date: February 12, 2015
    Applicant: SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
    Inventors: Oh Young Bang, Gyeong Joon Moon, Yeon Hee Cho, Suk Jae Kim, Dong Hee Kim, Ji Hee Sung